We've made big impact over the past ten years. But, our work heading into 2020 and beyond is far from over.

Founder and CEO, Aledade

The Illusions and Temptations of Successful M&A

What we can learn from industries beyond healthcare where M&A activities have generated greater returns.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

The possibilities of new Asian health ecosystems and care models are here (and, they’re here to stay).

Regional Head, Education, Research, Healthcare & Not for Profit, Amazon Web Services
Managing Director, Asia Health and Global Health Innovation, AXA

How not to be fooled, and why the old way is old news.

Principal, Health & Life Sciences, Oliver Wyman

Analysis on how Cigna/Express Scripts and Aetna/CVS may benefit consumers.

Senior Principal, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe

How to ensure medications work as intended for different patient populations.

Chief Executive Officer, Aetion
Partner, Health & Life Sciences, Oliver Wyman

When it comes to your current risk management strategy, don't let the trees grow to the sky.

Principal and Stop Loss Specialty Practice Leader, Mercer
Senior Partner, Mercer

Quality, not quantity, will drive the next wave of partnerships and product launches.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

An analysis of annual premiums by federal poverty level.

Practice Leader, Oliver Wyman Actuarial Consulting

How to empower LGBTQ+ employees to bring their entire selves to work.

Talent Strategy & HR Transformation Consultant, Mercer

Insights in your inbox

Subscribe
Load More